ATF3 and cancer: This study proposed that in cancer cells with β-catenin mutations, such as HCT116 cells, ATF3 transcription is constitutively activated through the β-catenin/TCF4 binding, but over-expressed ATF3 exhibits a tumor suppressive function by repressing cancer migration and invasion.